Are heterobivalent GRPR- and VPAC1R-bispecific radiopeptides suitable for efficient in vivo tumor imaging of prostate carcinomas?
Receptor-specific peptides labeled with positron emitters play an important role in the clinical imaging of several malignancies by positron emission tomography (PET). Radiolabeled heterobivalent bispecific peptidic ligands (HBPLs) can target more than one receptor type and by this - besides exhibit...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
15 September 2021
|
| In: |
Bioorganic & medicinal chemistry letters
Year: 2021, Jahrgang: 48, Pages: 1-7 |
| ISSN: | 1464-3405 |
| DOI: | 10.1016/j.bmcl.2021.128241 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.bmcl.2021.128241 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0960894X21004686 
|
| Verfasserangaben: | Simon Lindner, Henning Rudolf, Giovanna Palumbo, Rosel Oos, Melissa Antons, Ralph Hübner, Peter Bartenstein, Ralf Schirrmacher, Björn Wängler, Carmen Wängler |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1833248260 | ||
| 003 | DE-627 | ||
| 005 | 20230707010428.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230206s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bmcl.2021.128241 |2 doi | |
| 035 | |a (DE-627)1833248260 | ||
| 035 | |a (DE-599)KXP1833248260 | ||
| 035 | |a (OCoLC)1389538022 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Lindner, Simon |d 1982- |e VerfasserIn |0 (DE-588)1027458564 |0 (DE-627)729155641 |0 (DE-576)373231369 |4 aut | |
| 245 | 1 | 0 | |a Are heterobivalent GRPR- and VPAC1R-bispecific radiopeptides suitable for efficient in vivo tumor imaging of prostate carcinomas? |c Simon Lindner, Henning Rudolf, Giovanna Palumbo, Rosel Oos, Melissa Antons, Ralph Hübner, Peter Bartenstein, Ralf Schirrmacher, Björn Wängler, Carmen Wängler |
| 264 | 1 | |c 15 September 2021 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 06.02.2023 | ||
| 520 | |a Receptor-specific peptides labeled with positron emitters play an important role in the clinical imaging of several malignancies by positron emission tomography (PET). Radiolabeled heterobivalent bispecific peptidic ligands (HBPLs) can target more than one receptor type and by this - besides exhibiting other advantages - increase tumor imaging sensitivity. In the present study, we show the initial in vivo evaluation of the most potent heterobivalent gastrin-releasing peptide receptor (GRPR)- and vasoactive intestinal peptide receptor subtype 1 (VPAC1R)-bispecific radiotracer and determined its tumor visualization potential via PET/CT imaging. For this purpose, the most potent described HBPL was synthesized together with its partly scrambled heterobivalent monospecific homologs and its monovalent counterparts. The agents were efficiently labeled with 68Ga3+ and evaluated in an initial PET/CT tumor imaging study in a human prostate carcinoma (PCa) xenograft rat tumor model established for this purpose. None of the three 68Ga-HBPLs enabled a clear tumor visualization and a considerably higher involvement in receptor-mediated uptake was found for the GRPR-binding part of the molecule than for the VPAC1R-binding one. Of the monovalent radiotracers, only [68Ga]Ga-NODA-GA-PESIN could efficiently delineate the tumor, confirming the results. Thus, this work sets the direction for future developments in the field of GRPR- and VPAC1R-bispecific radioligands, which should be based on other VPAC1R-specific peptides than PACAP-27. | ||
| 650 | 4 | |a Bispecific tumor targeting | |
| 650 | 4 | |a GRPR | |
| 650 | 4 | |a Heterobivalent peptidic ligands | |
| 650 | 4 | |a Human prostate carcinoma | |
| 650 | 4 | |a PACAP-27 | |
| 650 | 4 | |a PESIN | |
| 650 | 4 | |a VCaP tumor xenograft | |
| 650 | 4 | |a VPACR | |
| 700 | 1 | |a Rudolf, Henning |e VerfasserIn |0 (DE-588)1044452633 |0 (DE-627)772065624 |0 (DE-576)397674406 |4 aut | |
| 700 | 1 | |a Palumbo, Giovanna |e VerfasserIn |4 aut | |
| 700 | 1 | |a Oos, Rosel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Antons, Melissa Joy |d 1993- |e VerfasserIn |0 (DE-588)1268949833 |0 (DE-627)1817579134 |4 aut | |
| 700 | 1 | |a Hübner, Ralph |d 1976- |e VerfasserIn |0 (DE-588)1015445977 |0 (DE-627)669100501 |0 (DE-576)350632170 |4 aut | |
| 700 | 1 | |a Bartenstein, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schirrmacher, Ralf |d 1970- |e VerfasserIn |0 (DE-588)121796124 |0 (DE-627)705656918 |0 (DE-576)292889518 |4 aut | |
| 700 | 1 | |a Wängler, Björn |d 1975- |e VerfasserIn |0 (DE-588)129702218 |0 (DE-627)477593909 |0 (DE-576)297793888 |4 aut | |
| 700 | 1 | |a Wängler, Carmen |d 1978- |e VerfasserIn |0 (DE-588)133775593 |0 (DE-627)556368177 |0 (DE-576)30009230X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bioorganic & medicinal chemistry letters |d Amsterdam [u.a.] : Elsevier Science, 1991 |g 48(2021) vom: Sept., Artikel-ID 128241, Seite 1-7 |h Online-Ressource |w (DE-627)306717522 |w (DE-600)1501505-1 |w (DE-576)110916573 |x 1464-3405 |7 nnas |a Are heterobivalent GRPR- and VPAC1R-bispecific radiopeptides suitable for efficient in vivo tumor imaging of prostate carcinomas? |
| 773 | 1 | 8 | |g volume:48 |g year:2021 |g month:09 |g elocationid:128241 |g pages:1-7 |g extent:7 |a Are heterobivalent GRPR- and VPAC1R-bispecific radiopeptides suitable for efficient in vivo tumor imaging of prostate carcinomas? |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.bmcl.2021.128241 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0960894X21004686 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230206 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 133775593 |a Wängler, Carmen |m 133775593:Wängler, Carmen |d 60000 |d 62900 |e 60000PW133775593 |e 62900PW133775593 |k 0/60000/ |k 1/60000/62900/ |p 10 |y j | ||
| 998 | |g 129702218 |a Wängler, Björn |m 129702218:Wängler, Björn |d 60000 |d 62900 |e 60000PW129702218 |e 62900PW129702218 |k 0/60000/ |k 1/60000/62900/ |p 9 | ||
| 998 | |g 1015445977 |a Hübner, Ralph |m 1015445977:Hübner, Ralph |d 60000 |d 62900 |e 60000PH1015445977 |e 62900PH1015445977 |k 0/60000/ |k 1/60000/62900/ |p 6 | ||
| 998 | |g 1044452633 |a Rudolf, Henning |m 1044452633:Rudolf, Henning |d 60000 |d 62900 |e 60000PR1044452633 |e 62900PR1044452633 |k 0/60000/ |k 1/60000/62900/ |p 2 | ||
| 999 | |a KXP-PPN1833248260 |e 4267370834 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1833248260"],"doi":["10.1016/j.bmcl.2021.128241"]},"language":["eng"],"origin":[{"dateIssuedDisp":"15 September 2021","dateIssuedKey":"2021"}],"title":[{"title_sort":"Are heterobivalent GRPR- and VPAC1R-bispecific radiopeptides suitable for efficient in vivo tumor imaging of prostate carcinomas?","title":"Are heterobivalent GRPR- and VPAC1R-bispecific radiopeptides suitable for efficient in vivo tumor imaging of prostate carcinomas?"}],"person":[{"family":"Lindner","display":"Lindner, Simon","given":"Simon","role":"aut"},{"display":"Rudolf, Henning","family":"Rudolf","given":"Henning","role":"aut"},{"role":"aut","given":"Giovanna","display":"Palumbo, Giovanna","family":"Palumbo"},{"role":"aut","given":"Rosel","display":"Oos, Rosel","family":"Oos"},{"family":"Antons","display":"Antons, Melissa Joy","given":"Melissa Joy","role":"aut"},{"family":"Hübner","display":"Hübner, Ralph","given":"Ralph","role":"aut"},{"given":"Peter","family":"Bartenstein","display":"Bartenstein, Peter","role":"aut"},{"given":"Ralf","family":"Schirrmacher","display":"Schirrmacher, Ralf","role":"aut"},{"given":"Björn","family":"Wängler","display":"Wängler, Björn","role":"aut"},{"given":"Carmen","family":"Wängler","display":"Wängler, Carmen","role":"aut"}],"physDesc":[{"extent":"7 S."}],"relHost":[{"title":[{"title":"Bioorganic & medicinal chemistry letters","subtitle":"a Tetrahedron publication for rapid dissemination of preliminary communications on all aspects of bioorganic chemistry, medicinal chemistry, bioinorganic chemistry and related disciplines","title_sort":"Bioorganic & medicinal chemistry letters"}],"physDesc":[{"extent":"Online-Ressource"}],"titleAlt":[{"title":"Bioorganic and medicinal chemistry letters"}],"part":{"extent":"7","year":"2021","volume":"48","text":"48(2021) vom: Sept., Artikel-ID 128241, Seite 1-7","pages":"1-7"},"origin":[{"publisher":"Elsevier Science","dateIssuedKey":"1991","dateIssuedDisp":"1991-","publisherPlace":"Amsterdam [u.a.]"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"zdb":["1501505-1"],"issn":["1464-3405"],"eki":["306717522"]},"language":["eng"],"pubHistory":["1.1991 -"],"note":["Gesehen am 09.11.2020"],"recId":"306717522","disp":"Are heterobivalent GRPR- and VPAC1R-bispecific radiopeptides suitable for efficient in vivo tumor imaging of prostate carcinomas?Bioorganic & medicinal chemistry letters"}],"name":{"displayForm":["Simon Lindner, Henning Rudolf, Giovanna Palumbo, Rosel Oos, Melissa Antons, Ralph Hübner, Peter Bartenstein, Ralf Schirrmacher, Björn Wängler, Carmen Wängler"]},"recId":"1833248260","note":["Gesehen am 06.02.2023"]} | ||
| SRT | |a LINDNERSIMAREHETEROB1520 | ||